Teladoc Health Inc.

NYSE: TDOC · Real-Time Price · USD
7.50
0.20 (2.74%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.20%
After-hours: Aug 15, 2025, 07:58 PM EDT

Teladoc Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
631.9M 629.37M 640.49M 640.51M 642.44M 646.13M 660.53M 660.24M 652.41M 629.24M 637.71M 611.4M 592.38M 565.35M 554.24M 521.66M 503.14M 453.68M
Cost of Revenue
190.54M 196.83M 188.93M 179.75M 284.62M 292.43M 193.42M 185.96M 190.54M 190.11M 188.87M 185.62M 182.47M 187.03M 174.99M 169.04M 160.27M 145.96M
Gross Profit
441.36M 432.54M 451.56M 460.76M 357.82M 353.7M 467.1M 474.28M 461.87M 439.14M 448.84M 425.78M 409.91M 378.32M 379.25M 352.62M 342.87M 307.72M
Operating Income
-54.38M -120.61M -48.22M -44.4M -49.19M -77.08M -87.13M -64.72M -47.68M -49.01M 3.75B -70.14M -63.66M -64.87M -37.27M -60.58M -78.95M -84.68M
Interest Income
-10.06M 12.67M 14.23M 15.33M 13.57M 13.94M 13.71M 12.61M 11.56M 8.91M 1.89M 4.8M 1.23M n/a n/a n/a n/a n/a
Pretax Income
-40.42M -111.27M -48.17M -32.5M -833.79M -79.2M -25.38M -59.56M -66.13M -68.55M -3.81B -74.65M -3.1B -6.67B -60.73M -80.7M -130.62M -112.61M
Net Income
-32.66M -93.01M -48.41M -33.28M -837.67M -81.89M -28.89M -57.07M -65.18M -69.23M -3.81B -73.48M -3.1B -6.67B -10.98M -84.34M -133.82M -199.65M
Selling & General & Admin
275.66M 329.65M 327.45M 339.17M 330.26M 349.39M 148.09M 301.87M 358.13M 345.43M 322.57M 346.1M 333.37M 296.85M 290.92M 276.7M 278.29M 259.4M
Research & Development
68.78M 69.96M 76.75M 72.38M 76.75M 81.39M 89.94M 84.29M 87.31M 86.98M 82.93M 87.81M 80.83M 87.41M 72.87M 80.25M 80.76M 78.01M
Other Expenses
151.3M 202.23M 148.3M 93.61M -563K -370K n/a -1.79M 75.47M 69.78M 75.72M 62.01M 59.37M 58.93M 52.33M 51.91M 51.34M 48.66M
Operating Expenses
495.75M 553.15M 499.78M 505.16M 407.01M 430.78M 238.03M 386.16M 520.9M 502.19M 481.21M 495.92M 473.57M 443.2M 416.12M 408.85M 410.39M 386.07M
Interest Expense
4.47M 5.76M 6.85M 5.66M 5.65M 5.65M 5.54M 5.65M 5.83M 5.26M n/a 6.15M 5.56M 5.48M 18.87M 18.89M 20.47M 22.13M
Selling & Marketing Expenses
167.55M 216.88M 227.45M 224.93M 220.71M 237.69M 53.01M 186.15M 218.41M 231.28M 202.72M 233.55M 222.5M 191.93M 172.32M 173.68M 167.08M 154.23M
Cost & Expenses
686.28M 749.98M 688.71M 684.91M 691.63M 723.21M 431.45M 572.12M 711.44M 692.3M 670.09M 681.54M 656.04M 630.22M 591.11M 577.89M 570.67M 532.03M
Income Tax Expense
-7.76M -18.25M 238K 780K 3.88M 2.69M 3.52M -2.48M -952K 681K -1.84M -1.17M -1.19M 388K -49.74M 3.64M 3.2M 87.04M
Shares Outstanding (Basic)
175.92M 174.15M 172.76M 170.23M 170.23M 167.73M 166.06M 165.12M 164.17M 162.92M 162.17M 161.73M 161.38M 160.53M 159.94M 159.44M 156.06M 152.17M
Shares Outstanding (Diluted)
175.92M 174.15M 172.76M 171.5M 170.23M 167.73M 166.06M 165.12M 164.17M 162.92M 162.17M 161.73M 161.38M 160.53M 159.94M 159.44M 156.06M 152.17M
EPS (Basic)
-0.19 -0.53 -0.28 -0.2 -4.92 -0.49 -0.17 -0.35 -0.4 -0.42 -23.49 -0.45 -19.22 -41.58 -0.07 -0.53 -0.86 -1.31
EPS (Diluted)
-0.19 -0.53 -0.28 -0.19 -4.92 -0.49 -0.17 -0.35 -0.4 -0.42 -23.49 -0.45 -19.22 -41.58 -0.07 -0.53 -0.86 -1.31
EBITDA
-54.38M -120.61M 50.35M 64.98M -729.29M 26.95M 81.65M 40.39M 15.17M 4.97M -3.73B -3.06M -3.03B -11.87M 15.18M -6.73M -54.24M -41.83M
EBIT
-35.95M -105.5M -41.33M -26.84M -828.14M -73.55M -19.84M -53.91M -60.29M -68.55M -3.81B -68.5M -3.1B -64.87M -41.85M -61.8M -110.15M -90.48M
Depreciation & Amortization
n/a -15.11M 91.67M 91.81M 98.85M 100.5M 101.48M 97.49M 79.51M 73.52M 78.88M 65.43M 63.45M 62.88M 57.03M 55.07M 55.91M 50.37M